Microbiota Diversity in Non-Small Cell Lung Cancer Gut and Mouth Cavity Microbiota Diversity in Non-Small Cell Lung Cancer Patients
Jazyk angličtina Země Polsko Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
38103007
PubMed Central
PMC10725158
DOI
10.33073/pjm-2023-044
PII: pjm-2023-044
Knihovny.cz E-zdroje
- Klíčová slova
- lung cancer, microbiota, non-small cell lung carcinoma, oncogenic mutations,
- MeSH
- adenokarcinom * MeSH
- lidé MeSH
- mikrobiota * MeSH
- nádory plic * mikrobiologie patologie MeSH
- nemalobuněčný karcinom plic * mikrobiologie patologie MeSH
- spinocelulární karcinom * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Lung malignancies have a substantial impact on cancer incidence and mortality worldwide. Even though many factors involved in the development of the disease are known, many questions remain unanswered. Previous studies suggest that the intestinal microbiota may have a role in developing malignant diseases. According to some findings, the microbiota has proven to be a key modulator of carcinogenic processes and the immune response against cancer cells, potentially influencing the effectiveness of immunotherapy. In our study, we characterized culturable microorganisms associated with non-small cell lung cancer (NSCLC) that can be recovered from rectal swabs and mouthwash. In addition, we also explored differences in the culturable microbiota with two main types of NSCLC - adenocarcinoma (ADC) and squamous cell carcinoma (SCC). With 141 patients included in the study (86 ADC and 55 SCC cases), a significant difference was observed between the two types in seven bacterial species (Collinsella, Corynebacterium, Klebsiella, Lactobacillus, Neisseria, Rothia, and Streptococcus), including the site of origin. The relationship between microbial dysbiosis and lung cancer is poorly understood; future research could shed light on the links between gut microbiota and lung cancer development.
Department of Surgical Studies University Hospital Ostrava Ostrava Czech Republic
Faculty of Medicine University of Ostrava Ostrava Czech Republic
Faculty of Mining and Geology VŠB Technical University of Ostrava Ostrava Czech Republic
Nanotechnology Centre CEET VŠB Technical University of Ostrava Ostrava Czech Republic
Surgical Clinic Thomas Bat'a Regional Hospital Prague Czech Republic
Zobrazit více v PubMed
Asam D, Spellerberg B. Molecular pathogenicity of Streptococcus anginosus Mol Oral Microbiol 2014 NaN29(4):145. doi: 10.1111/omi.12056. . . ; ( ): –. . https://doi.org/ PubMed DOI
Chen J, Domingue JC, Sears CL. Microbiota dysbiosis in select human cancers: Evidence of association and causality Semin Immunol 2017 NaN32:25. doi: 10.1016/j.smim.2017.08.001. . . ; : –. . https://doi.org/ PubMed DOI PMC
Coussens LM, Zitvogel L, Palucka AK. Neutralizing tumor-promoting chronic inflammation: A magic bullet? Science 2013 NaN339(6117):286. doi: 10.1126/science.1232227. . ; ( ): –. . https://doi.org/ PubMed DOI PMC
Davis NM, Proctor DM, Holmes SP, Relman DA, Callahan BJ. Simple statistical identification and removal of contaminant sequences in marker-gene and metagenomics data. . PubMed PMC
Dickson RP, Huffnagle GB. The lung microbiome: New principles for respiratory bacteriology in health and disease PLoS Pathog 2015 NaN11(7):2023044. doi: 10.1371/journal.ppat.1004923. . . ; ( ) : e1004923. https://doi.org/ PubMed DOI PMC
Kassambara A, Kosinski M, Biecek P. survminer: Drawing Survival Curves using ‘ggplot2’. Vienna (Austria): R Foundation for Statistical Computing; 2021. [cited 2023 Aug 7]. . R package version: 0.4.9. : ; . [ ]. Available from https://CRAN.R-project.org/package=survminer.
Enaud R, Prevel R, Ciarlo E, Beaufils F, Wieёrs G, Guery B, Delhaes L. The gut-lung axis in health and respiratory diseases: A place for inter-organ and inter-kingdom crosstalks Front Cell Infect Microbiol 2020 NaN10:9. doi: 10.3389/fcimb.2020.00009. . . ; : . https://doi.org/ PubMed DOI PMC
Ettinger DS, Akerley W, Borghaei H, Chang AC, Cheney RT, Chirieac LR, D’Amico TA, Demmy TL, Govindan R, Grannis FW, Jr, et al. Non-small cell lung cancer, version 2.2013 J Natl Compr Canc Netw 2013 NaN11(6):645. doi: 10.6004/jnccn.2013.0084. . . . ; ( ): –. . https://doi.org/ PubMed DOI
Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients Science 2018 NaN359(6371):97. doi: 10.1126/science.aan4236. . . . ; ( ): –. . https://doi.org/ PubMed DOI PMC
Hashizume-Takizawa T, Yamaguchi Y, Kobayashi R, Shinozaki-Kuwahara N, Saito M, Kurita-Ochiai T. Oral challenge with Streptococcus sanguinis induces aortic inflammation and accelerates atherosclerosis in spontaneously hyperlipidemic mice Biochem Biophys Res Commun 2019 NaN520(3):507. doi: 10.1016/j.bbrc.2019.10.057. . . ; ( ): –. . https://doi.org/ PubMed DOI
Lê S, Josse J, Husson F. FactoMineR: An R package for multivariate analysis J Stat Soft 2008;25(1):1. doi: 10.18637/jss.v025.i01. . . ; ( ): –. . https://doi.org/ DOI
Liang HY, Li XL, Yu XS, Guan P, Yin ZH, He QC, Zhou BS. Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: A systematic review Int J Cancer 2009 NaN125(12):2936. doi: 10.1002/ijc.24636. . . ; ( ): –. . https://doi.org/ PubMed DOI
Lindeman NI, Cagle PT, Beasley MB, Chitale DA, Dacic S, Giaccone G, Jenkins RB, Kwiatkowski DJ, Saldivar JS, Squire J, et al. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology J Thorac Oncol 2013 NaN8(7):823. doi: 10.1097/JTO.0b013e318290868f. . . . ; ( ): –. . https://doi.org/ PubMed DOI PMC
Liu X, Cheng Y, Zang D, Zhang M, Li X, Liu D, Gao B, Zhou H, Sun J, Han X, et al. The role of gut microbiota in lung cancer: From carcinogenesis to immunotherapy Front Oncol 2021 NaN11:720842. doi: 10.3389/fonc.2021.720842. . . . ; : . https://doi.org/ PubMed DOI PMC
Mao Q, Jiang F, Yin R, Wang J, Xia W, Dong G, Ma W, Yang Y, Xu L, Hu J. Interplay between the lung microbiome and lung cancer Cancer Lett 2018 NaN415:40. doi: 10.1016/j.canlet.2017.11.036. . . ; : –. . https://doi.org/ PubMed DOI
de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, Plummer M. Global burden of cancers attributable to infections in 2008: A review and synthetic analysis Lancet Oncol 2012 NaN13(6):607. doi: 10.1016/S1470-2045(12)70137-7. . . ; ( ): –. . https://doi.org/ PubMed DOI
Matson V, Fessler J, Bao R, Chongsuwat T, Zha Y, Alegre ML, Luke JJ, Gajewski TF. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients Science 2018 NaN359(6371):104. doi: 10.1126/science.aao3290. . . ; ( ): –. . https://doi.org/ PubMed DOI PMC
Mazières J, Zalcman G, Crinò L, Biondani P, Barlesi F, Filleron T, Dingemans AM, Léna H, Monnet I, Rothschild SI, et al. Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort J Clin Oncol 2015 NaN33(9):992. doi: 10.1200/JCO.2014.58.3302. . . . ; ( ): –. . https://doi.org/ PubMed DOI
Navratilova L, Bardon J, Novotny R, Zatloukal J, Jakubec P, Kolek V, Zapalka M, Kopriva F, Prochazkova P, Raclavsky V. The Streptococcus milleri group in chronic obstructive pulmonary disease Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2016 NaN160(3):378. doi: 10.5507/bp.2016.017. . . ; ( ): –. . https://doi.org/ PubMed DOI
Nejman D, Livyatan I, Fuks G, Gavert N, Zwang Y, Geller LT, Rotter-Maskowitz A, Weiser R, Mallel G, Gigi E, et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria Science 2020 NaN368(6494):973. doi: 10.1126/science.aay9189. . . . ; ( ): –. . https://doi.org/ PubMed DOI PMC
Oxnard GR, Binder A, Jänne PA. New targetable oncogenes in nonsmall-cell lung cancer J Clin Oncol 2013 NaN31(8):1097. doi: 10.1200/JCO.2012.42.9829. . . ; ( ): –. . https://doi.org/ PubMed DOI PMC
Parkins MD, Sibley CD, Surette MG, Rabin HR. The Streptococcus milleri group--an unrecognized cause of disease in cystic fibrosis: A case series and literature review Pediatr Pulmonol 2008 NaN43(5):490. doi: 10.1002/ppul.20809. . . ; ( ): –. . https://doi.org/ PubMed DOI
R Core Team . R: A language and environment for statistical computing. Vienna (Austria): R Foundation for Statistical Computing; 2021. [cited 2023 Aug 7]. . . : ; [ ]. Available from https://www.R-project.org.
Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors Science 2018 NaN359(6371):91. doi: 10.1126/science.aan3706. . . . ; ( ): –. . https://doi.org/ PubMed DOI
Sędzikowska A, Szablewski L. Human gut microbiota in health and selected cancers Int J Mol Sci 2021 NaN22(24):13440. doi: 10.3390/ijms222413440. . . ; ( ): . https://doi.org/ PubMed DOI PMC
Shaw AT, Ou SH, Bang YJ, Camidge DR, Solomon BJ, Salgia R, Riely GJ, Varella-Garcia M, Shapiro GI, Costa DB, et al. Crizotinib in ROS1-rearranged non-small-cell lung cancer N Engl J Med 2014 NaN371(21):1963. doi: 10.1056/NEJMoa1406766. . . . ; ( ): –. . https://doi.org/ PubMed DOI PMC
Song F, Qureshi AA, Gao X, Li T, Han J. Smoking and risk of skin cancer: A prospective analysis and a meta-analysis Int J Epidemiol 2012 NaN41(6):1694. doi: 10.1093/ije/dys146. . . ; ( ): –. . https://doi.org/ PubMed DOI PMC
Song Z, Zheng Y, Wang X, Su H, Zhang Y, Song Y. ALK and ROS1 rearrangements, coexistence and treatment in epidermal growth factor receptor-wild type lung adenocarcinoma: A multicenter study of 732 cases J Thorac Dis 2017 NaN9(10):3919. doi: 10.21037/jtd.2017.09.79. . . ; ( ): –. . https://doi.org/ PubMed DOI PMC
Human Microbiome Project Consortium Structure, function and diversity of the healthy human microbiome Nature 2012 NaN486(7402):207. doi: 10.1038/nature11234. . . . ; ( ): –. . https://doi.org/ PubMed DOI PMC
Therneau T. A Package for Survival Analysis in R. Vienna (Austria): R Foundation for Statistical Computing; 2023. [cited 2023 Aug 7]. . R package version 3.5–7 [Internet]. : ; [ ]. Available from https://CRAN.R-project.org/package=survival.
Tsai MS, Chen YY, Chen WC, Chen MF. Streptococcus mutans promotes tumor progression in oral squamous cell carcinoma J Cancer 2022 NaN13(12):3358. doi: 10.7150/jca.73310. . . ; ( ): –. . https://doi.org/ PubMed DOI PMC
Tsay JJ, Wu BG, Badri MH, Clemente JC, Shen N, Meyn P, Li Y, Yie TA, Lhakhang T, Olsen E, et al. Airway microbiota is associated with upregulation of the PI3K pathway in lung cancer Am J Respir Crit Care Med 2018 NaN198(9):1188. doi: 10.1164/rccm.201710-2118OC. . . . ; ( ): –. . https://doi.org/ PubMed DOI PMC
Wong-Rolle A, Wei HK, Zhao C, Jin C. Unexpected guests in the tumor microenvironment: Microbiome in cancer Protein Cell 2021 NaN12(5):426. doi: 10.1007/s13238-020-00813-8. . . ; ( ): –. . https://doi.org/ PubMed DOI PMC
Yang JJ, Yu D, Xiang YB, Blot W, White E, Robien K, Sinha R, Park Y, Takata Y, Lazovich D, et al. Association of dietary fiber and yogurt consumption with lung cancer risk: A pooled analysis JAMA Oncol 2020 NaN6(2):2023044. doi: 10.1001/jamaoncol.2019.4107. . . . ; ( ) :e194107. https://doi.org/ PubMed DOI PMC
Yue T, Li J, Zhu J, Zuo S, Wang X, Liu Y, Liu J, Liu X, Wang P, Chen S. Hydrogen sulfide creates a favorable immune microenvironment for colon cancer Cancer Res 2023 NaN83(4):595. doi: 10.1158/0008-5472.CAN-22-1837. . . ; ( ): –. . https://doi.org/ PubMed DOI
Zhang WL, Wang SS, Wang HF, Tang YJ, Tang YL, Liang XH. Who is who in oral cancer? Exp Cell Res 2019 NaN384(2):111634. doi: 10.1016/j.yexcr.2019.111634. . ; ( ): . https://doi.org/ PubMed DOI
Zhou CB, Pan SY, Jin P, Deng JW, Xue JH, Ma XY, Xie YH, Cao H, Liu Q, Xie WF, et al. Fecal signatures of Streptococcus anginosus and Streptococcus constellatus for noninvasive screening and early warning of gastric cancer Gastroenterology 2022 NaN162(7):1933. doi: 10.1053/j.gastro.2022.02.015. . . . ; ( ): –. .e18. https://doi.org/ PubMed DOI